DiscoverPeople of Pathology PodcastEpisode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network
Episode 213: Arun Ananth and Tom Gallo -  Data As An Asset With Proscia’s Diagnostic Network

Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network

Update: 2025-08-18
Share

Description

Today my guests are Arun Ananth, CCO and Tom Gallo, CFO from Proscia.


What we discuss with Arun and Tom:



  • Introduction to Proscia’s Diagnostic Network

  • Reshaping the economics of pathology

  • Economic opportunities in digital pathology

  • Data as an asset in biomarker discovery

  • Clinical trials as use cases

  • Compliance and security in digital pathology

  • Pathology's central role in treatment

  • Accelerating digital adoption and ROI

  • Patient benefits and clinical trials

  • Risks and barriers in digital pathology

  • Advice for labs considering digital pathology

  • Market adoption and future vision


Links for this episode:


The Path to PathA


Pathologists' Assistant Shadowing Network


Health Podcast Network


 LabVine Learning


Dress A Med scrubs


Digital Pathology Club


 


Proscia Cements Leadership in Diagnostic Pathology with 400% Growth in Daily Cases


Rewiring the Laboratory’s Bottom Line: Moving Towards Digital Pathology as a Profit Center


 


People of Pathology Podcast:


Twitter


Instagram


 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 213: Arun Ananth and Tom Gallo -  Data As An Asset With Proscia’s Diagnostic Network

Episode 213: Arun Ananth and Tom Gallo - Data As An Asset With Proscia’s Diagnostic Network

peopleofpathology